Valuation ScenariosAdded to Geo Bargain list on April 27, 2009. ($4.15).
Data Inputs:
Fiscal Year Ends in December2008 Tax-Adjusted non-GAAP EPS: $0.50 (previous calculation was $0.54)
a CBPO does not pay a full U.S. tax rate. Therefore, all EPS numbers have been adjusted by the GeoTeam® to reflect an average marginal tax rate of 36%. EPS are Non-GAAP figures and excludes non-cash compensation expense. EPS number are non-GAAP. Non-GAAP EPS Figures exclude certain non-operating gains and losses as well as certain non-cash items. Non-GAAP information should not be viewed in isolation or as a substitute for reported, or GAAP information . For a more complete explanation of the company's definition of non-GAAP please refer to its financial press releases. The GeoTeam® non-GAAP figures may, from time to time, differ from company supplied figures.
b. The company issued net income guidance of $18 million to $22 million, but did not provide EPS guidance. The GeoTeam® used the March 31, 2009 outstanding share count of 21,434,942 to calculate an implied 2009 EPS figure. The lack of EPS guidance may cause some investors to infer that dilutive events are expected to occur in the near future. However, per the 10K page 45, it appears that the company does not need to raise cash via a capital raise:
"With the bank credit facilities that are available to us and other financing activities, we expect that cash on hand, funds generated from our operations and funds generated from companies that we may acquire in the future will be sufficient to satisfy our current and future commitments for at least the next twelve months."
Short-Term Valuation Scenarios
a CBPO does not pay a full U.S. tax rate. Therefore, all EPS numbers have been adjusted by the GeoTeam® to reflect an average marginal tax rate of 36%. EPS are Non-GAAP figures and excludes non-cash compensation expense.
Biotech
ctbb.com.cn